Original language of petition: English
Petition to Address the Opioid Crisis
We, the undersigned residents of Canada, draw the attention of the House of Commons in Parliament Assembled to the following:
Oover 4000 Canadians died in 2017 and over 2,800 in 2016 due to preventable opioid overdose resulting from fentanyl-poisoned sources;
The number of preventable deaths has surpassed the total number of deaths of all other Public Health Emergencies in the last 20 years including SARS, H1N1, and Ebola;
Those who have died as a result of a preventable opioid overdose from fentanyl-poisoned sources were valued citizens of this country: our children, siblings, spouses, parents, family members, clients, friends;
Substance use is a normal part of human experience, documented across centuries and all over the world;
The current war on drugs has been costly and grossly ineffective and resulted in widespread stigma towards addiction and against those who use illicit drugs;
Criminalization of particular substances has resulted in the establishment of a drug trade that now traffics dangerous and lethal products, such as fentanyl;
Regulating to ensure safe sources, with proper measures and bylaws, will reduce the criminal element associated with street drugs;
Problematic substance use is a health issue and is not resolved through criminalizing personal possession and consumption; and
Decriminalization of personal possession is associated with dramatically reducing overdose deaths in the countries that have modernized their drug policy.
Therefore we, the undersigned, Citizens of Canada, call upon the Government of Canada to:
The Government of Canada recognizes that the overdose crisis is one of the most serious and unprecedented public health threats in Canada’s recent history, which is having devastating impacts on individuals, our friends and families, and communities across the country. Tragically, most recent national data indicates that 24,626 apparent opioid toxicity deaths occurred between January 2016 and June 2021. Fentanyl and its analogues continue to be major drivers of the crisis with as many as 87% of accidental apparent opioid toxicity deaths so far in 2021 (January to June) involving fentanyl.
The Government of Canada also recognizes that the complexity of this crisis has only increased due to the ongoing COVID-19 pandemic, leading to a more uncertain and dangerous illegal drug supply, resulting in tragic increases in overdose-related deaths across the country, as well as reduced access to health and social services, including life-saving harm reduction and treatment. Health Canada and the Public Health Agency of Canada have been working with provinces, territories, municipalities and other partners, including researchers, advocates and people with lived and living experience, to ensure that people who use drugs can continue to access the treatment, harm reduction and other services they need during the pandemic.
With respect to the request for a declaration of a national public health emergency, such a declaration is not required at the federal level to access important responses to the opioid overdose crisis. The comprehensive federal response has included legislative and regulatory enabling measures, new prescription guidelines, marketing restrictions, awareness campaigns, improvements to the knowledge base, and emergency funding to provinces and territories. These measures were all put in place without a formal declaration of a public health emergency.
The Government of Canada’s approach to substance use issues aims to be comprehensive, collaborative, and compassionate, guided by our federal drug strategy – the Canadian Drugs and Substances Strategy (CDSS). The CDSS takes a public health-focused approach, and lays out our framework for evidence-based actions to reduce the harms associated with substance use in Canada. It includes four key pillars – prevention, treatment, harm reduction, and enforcement. In the context of the worsening overdose crisis, the Government is placing particular focus on:
Since 2016, the Government of Canada has taken urgent action to address the overdose crisis through significant investments of over $700 million. Recent examples of key federal investments in this area include:
In addition to these investments, in order to prevent and reduce substance-related harms, the Government of Canada has undertaken a broad range of policy, legislative and regulatory actions, such as:
The Government of Canada has worked to implement a number of measures to divert people who use drugs away from the criminal justice system and towards health and social services. For example, the government passed the Good Samaritan Drug Overdose Act in May 2017, which provides some legal protection for individuals who seek emergency help during an overdose. On August 18, 2020, the Public Prosecution Service of Canada issued guidance to prosecutors, directing that alternatives to prosecution should be considered for personal possession offences, except when there are serious aggravating circumstances. In addition, Health Canada is currently funding a three-year project in Peterborough, Ontario, to develop a multi-sector response to direct people who use drugs away from the justice system and into care.
In March 2021, the Minister of Health commissioned an Expert Task Force on Substance Use, whose reports provide important advice with regards to alternatives to criminal penalties for simple possession of controlled substances and federal drug policy. Further to the Government’s commitment to reintroduce former Bill C-22 in the first 100 days of their mandate, on December 7, 2021, the Minister of Justice and Attorney General of Canada introduced Bill C-5, which proposes amendments to the Criminal Code and to the Controlled Drugs and Substances Act. Among other measures, this Bill would repeal mandatory minimum penalties for drug related-offences, and would require prosecutors to consider alternative measures to laying charges or prosecuting individuals for simple possession of drugs, including diversion to treatment programs, giving a warning, or taking no further action. The Government of Canada will continue to work with provincial and municipal officials on options to address their regional needs and help people who use drugs to get the support they need.
The Government of Canada has taken actions to reduce barriers to providing people who use drugs with a safer, pharmaceutical-grade alternative to the toxic illegal drug supply. On August 24, 2020, the Minister of Health sent a letter to Provincial and Territorial Ministers of Health and regulatory colleges to encourage the provision of a full spectrum of care options to people who use drugs, including access to a safer supply. In addition, Health Canada has issued class exemptions to ease restrictions on the transportation of controlled substances and reduced barriers for pharmacists to make it easier for people to access the medications they need during the COVID-19 pandemic while following public health advice, such as physical distancing. Through Health Canada’s Substance Use and Addictions Program, the Government of Canada is supporting 18 safer supply projects across 29 sites in British Columbia, Ontario, Quebec, and New Brunswick for a total investment of over $60 million. Seventeen of these projects are providing medications to people with substance use disorders as an alternative to the toxic illegal drug supply, and one is a National Community of Practice that focuses on the sharing of best practices and knowledge dissemination between providers of safer supply.
The Government of Canada has also taken a number of steps to provide options for those seeking treatment for severe substance use disorder. On April 25, 2019, the Minister of Health added diacetylmorphine to the List of Drugs for an Urgent Public Health Need. This addition makes it possible for provinces and territories to import this drug for the treatment of opioid use disorder. Amendments to federal regulations have also allowed health care practitioners to provide diacetylmorphine-assisted treatment outside of a hospital setting, if permitted by their province or territory. In addition, on May 1, 2019, Health Canada approved the use of injectable hydromorphone by qualified health care professionals as a treatment for adults with severe opioid use disorder. This is the first approval of injectable hydromorphone for this purpose in the world.
The Government of Canada is also providing guidance and leadership on the prescribing, dispensing, and delivery of opioids and other narcotics during the pandemic. For instance, through funding from the Canadian Institutes of Health Research, the Canadian Research Initiative in Substance Misuse developed a series of national guidance documents related to substance use in the context of COVID-19. Health Canada has also assembled a toolkit to provide clarity on prescribing for the treatment of substance use disorder and/or to provide a safer supply. Furthermore, the Canadian Agency for Drugs and Technologies in Health published a rapid review of clinical and cost-effectiveness of injectable opioid agonist treatment for patients with opioid dependence.
The Government of Canada will continue to take a comprehensive, collaborative, and compassionate public health focused approach to addressing substance use. We will continue to work with civil society organizations, front line responders, academics, people with lived and living experience, and other key stakeholders to reduce opioid-related overdoses and deaths, and improve the health and wellbeing of Canadians who use drugs. The Government of Canada believes that substance use is a health issue, and is committed to examining all options and evidence to respond to the tragic increase in overdoses and to help save lives, while also ensuring the safety of communities across the country.
Only validated signatures are counted towards the total number of signatures.